Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

  title={Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.},
  author={Ronen Durst and Haim Danenberg and Ruth Gallily and Raphael Mechoulam and Keren Meir and Etty Grad and Ronen Beeri and Thea Pugatsch and Elizabet Tarsish and Chaim Lotan},
  journal={American journal of physiology. Heart and circulatory physiology},
  volume={293 6},
Cannabidiol (CBD) is a major, nonpsychoactive Cannabis constituent with anti-inflammatory activity mediated by enhancing adenosine signaling. Inasmuch as adenosine receptors are promising pharmaceutical targets for ischemic heart diseases, we tested the effect of CBD on ischemic rat hearts. For the in vivo studies, the left anterior descending coronary artery was transiently ligated for 30 min, and the rats were treated for 7 days with CBD (5 mg/kg ip) or vehicle. Cardiac function was studied… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 17 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 37 extracted citations


Publications referenced by this paper.
Showing 1-10 of 39 references

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based H3606 CBD PROTECTION FROM MYOCARDIAL ISCHEMIA REPERFUSION AJP-Heart Circ Physiol

  • DR Blake, P Robson, M Ho, RW Jubb, CS. McCabe
  • Rheumatology 45:
  • 2007
2 Excerpts

Endocannabinoids—The Brain and Body’s

  • ES Onaivi, T Sugiura, V. Di Marzo
  • Marijuana and Beyond. London: Taylor and Francis,
  • 2006

Similar Papers

Loading similar papers…